Tara Innovations LLC

Following are the articles published by Dr. Joshi

Publications

1. Contract Research Organization Roundtable, Hemant N. Joshi et al., Pharmaceutical Outsourcing, 12 (2) : 30, 32, 34, 36, 38, 40 and 42 (2011). 

2. In-house Contract Research and Manufacturing, Hemant N. Joshi, Pharmaceutical Outsourcing, 12 (1):  46, 48 and 50 (2011). 

3. Drug Development and Imperfect Design, Hemant N. Joshi, Int. J. Pharm. 343 : 1-3 (2007).

4. Review of Lipids in Drug Delivery Systems– Part II, Hemant N. Joshi and Navnit Shah, Am. Pharm. Reviews 8 : 120-126 (2005).
5. Review of Lipids in Drug Delivery Systems – Part I, Hemant N. Joshi and Navnit Shah, Am. Pharm. Reviews 8 : 70-78 (2005).
6. Summary Workshop Report: Biopharmaceutics Classification System – Implementation challenges and Extension opportunities, James Polli, Hemant N. Joshi et al., J. Pharm. Sci. 93 : 1375 – 1381 (2004).
7. Bioavailability Enhancement of a Poorly Water-Soluble Drug by Solid Dispersion in Polyethylene Glycol-Polysorbate 80 Mixture, Hemant N. Joshi, Ravindra W. Tejwani, Martha Davidovich, Vaishali P. Sahasrabudhe, Mohammed Jemal, Mohinder S. Bathala, Sailesh A. Varia and Abu T.M. Serajuddin, Int. J. Pharm. 269 : 251 – 258 (2004).
8. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport,       Sanna Tolle-Sanders, Andreas Grill, Hemant Joshi, Ram Kapil, Stefano Persiani and James E. Polli, J. Pharm. Sci. 92 : 1968 - 1980 (2003).
9. Study of Isopropyl Myristate Microemulsion Systems containing cyclodextrins to improve the solubility of 2 model hydrophobic drugs, Indranil Nandi, Mohammad Bari and Hemant N. Joshi, AAPS PharmSciTech 4, Article 10 (http://www.pharmscitech.org), (2003).
10. Analysis of Indian Pharmaceutical Industry with emphasis on Opportunities in 2005. Hemant N. Joshi, Pharm. Tech. 27: 74- 94 (2003).
11. Synergistic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone, Indranil Nandi, Mohammad Bari, Michelle Bateson and Hemant N. Joshi, AAPS PharmSciTech 4, Article 1 (http://www.pharmscitech.org), (2003).
12. Advantages of cultural diversity in the pharmacy workplace, Hemant N. Joshi and Prasanna Gore, J. Managed Pharm. Care 1: 83-84 (2001).
13. Study of phase behavior of polyethylene glycol-polysorbate 80, and polyethylene glycol-polysorbate 80-water mixtures, Ravindra Tejwani, Hemant N. Joshi, and Abu T.M. Serajuddin, J.Pharm. Sci. 89:946-950 (2000).
14. Photostability and transmittance of four commercially available plastic wraps, Hemant N. Joshi, Susan Farmicola, James L. Pazdan, and Patrick Carpenter, Pharm. Tech. 74, 76, 78, 80, 82, 129 (April 2000).
15. Differentiation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors by their relative lipophilicity, Hemant N. Joshi, Michael G. Fakes, and Abu T.M. Serajuddin, Pharm. Pharmacol. Commun. 5: 269-271 (1999).
16. Drug evaluation -Lintitriptâ, Joshi, HN, Investigational drug database (Current Drugs), June 1998.
17. Calorimetric evaluation of hydration of cholestyramine, H.N. Joshi and T.D. Wilson. J. Pharm. Pharmacol. 47: 188-192 (1995).
18. Calorimetric studies on dissolution of hydroxypropyl methylcellulose E5 (HPMC E5) in water. H.N. Joshi and T.D. Wilson. J. Pharm. Sci. 82 : 1033 - 1038 (1993).
19. Drug release from membranes of hyaluronic acid and its esters. H.N. Joshi, V.J. Stella and E.M. Topp, J. Controlled Rel. 20: 109 - 122 (1992).
20. Hydration in hyaluronic acid and its esters using differential scanning calorimetry. H.N. Joshi and E.M. Topp, Int. J. Pharm. 80 : 213 - 225 (1992).
21. Dosage forms from polymeric prodrugs : Hydrocortisone esters of hyaluronic acid. L.M. Beneditti, H.N. Joshi, L. Goei, J.A. Hunt, L. Callegaro, V.J. Stella, and E.M. Topp, New Polymeric Mater. 3: 41 - 48 (1991).
22. Polymeric prodrugs : Recent experience with devices formed from steroid esters of hyaluronic acid. H. Joshi, L. Hume, L. Beneditti, L. Callegaro, V. Stella and E. Topp, Book on the Proceedings of the Fourth International conference on polymers in medicine : Biomedical and pharmaceutical applications, Riva del Garda, Italy, September, 1990.
23. Diffusion and drug release in polymer films prepared from ester derivatives of hyaluronic acid. J.A. Hunt, H.N. Joshi, V.J. Stella and E.M. Topp, J. Controlled Rel. 12: 159 - 169 (1990).
24. Microwave drying in aqueous film coating : study on free films. H.N. Joshi, M. Kral, and E.M. Topp, Int. J. Pharm. 51 : 19 - 25 (1989).
25. Recent advances in drug delivery systems: Polymeric prodrugs. H.N. Joshi, Pharm. Tech. 12: 118 - 130 (1988).
26. Spectrophotometric determination of cation concentration in olfactory mucus (NSL 04959). H.N. Joshi, M.L. Getchell, B. Zielinski and T.V. Getchell,  Neuroscience Letters 82: 321 - 327 (1987).
27. Bioavailability of ten tetracycline formulations marketed in India. A.K. Kane, H.N. Joshi and H.P. Tipnis, Indian Drugs 21 : 229 - 232 (1983).
28. In-vitro availability studies of tetracycline products marketed in India. S.A. Kanvinde, H.N. Joshi, G.N. Chaudhari and H.P. Tipnis, Indian Drugs 20: 151 - 159 (1983).
29. Project report for The Indian Council of Medical Research, New Delhi, 1982. Title : Bioavailability study of tolbutamide and chlorpropamide formulations in human subjects.                       
30. Spectrophotometric determination of sulfamethoxazole and trimethoprim in cotrimaxazole tablets. H.N. Joshi, G.N. Chaudhari and H.P. Tipnis, Indian Drugs 19 : 446 - 450 (1982).

Scientific articles

Synergistic effect of PEG400 and cyclodextrin

http://www.springerlink.com/content/x2154j4654735485/fulltext.pdf

IPM Microemulsion with CD to improve solubility of hydrophobic drugs

http://www.springerlink.com/content/90855222562t77t7/fulltext.pdf

Cholestyramine Hydration

Hyaluronic acid & Ester films

HPMC E5 Water Interaction

Lipophilicity of Statins

General articles

CRO Roundtable

In-house CRO/CMO

Imperfect Drug Design

Analysis of Indian Pharmaceutical Industry

Microwave Drying in Film coating

Cultural diversity in Pharma Industry

PEG Tween Phase Diagram

Polymeric Prodrugs Review

Patents  (site under construction)

Salts of Nefazadone

http://www.freepatentsonline.com/EP0710653.pdf

Contraceptive agent with a teratogen

Salts of Elsamitrucin

Drug in the capsule shell

ODT & ODF for dry mouth ailments